Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is comparing Evenamide 15 mg bid with placebo for people with Treatment-resistant Schizophrenia. Participants receive Evenamide 15 mg bid or placebo and complete study visits and assessments.
This observational study is following people with Schizophrenia and Other psychosis, Cannabis Use Disorder, or Healthy to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether a digital support tool can help people with Schizophrenia or schizoaffective disorder. Participants take part in a digital support tool and complete follow-up assessments.
This observational study is looking at how a digital support tool works for people with Schizophrenia Spectrum and Other psychosis or Affective Psychoses in routine care. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This observational study is following people with Schizophrenia or schizoaffective disorder to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is comparing iTEST with Active Control for people with Schizophrenia Disorders, schizoaffective disorder, or psychosis. Participants receive iTEST or Active Control and complete study visits and assessments.
This study is comparing LB-102 (50 mg tablet) with placebo for people with Schizophrenia. Participants receive LB-102 (50 mg tablet) or placebo and complete study visits and assessments.
This observational study is following people with Schizophrenia or psychosis to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at whether a digital support tool can help people with Schizophrenia and Related Disorders. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether Physical Exercise can help people with severe mental illness. Participants take part in Physical Exercise and complete follow-up assessments.
This study is looking at whether cognitive behavioural therapy can help people with Treatment-refractory Schizophrenia or Treatment-resistant Schizophrenia. Participants take part in cognitive behavioural therapy and complete follow-up assessments.
This observational study is following people with Schizophrenia or Psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with Healthy Participants or Schizophrenia Diagnosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether SEP-363856 can help people with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether questionnaires and follow-up can help people with With Schizophrenia-like Disorders. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is comparing iloperidone with placebo for people with Schizophrenia. Participants receive iloperidone or placebo and complete study visits and assessments.
This observational study is following people with Smoking Cessation, Nicotine Addiction, or Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at care and outcomes for people with Schizophrenia or schizoaffective disorder. Some participants may receive iTBS, then Sham instead of the study treatment, and direct benefit is not guaranteed.
This study is comparing Cannabidiol oral solution with placebo for people with Early Psychosis. Participants receive Cannabidiol oral solution or placebo and complete study visits and assessments.
This observational study is following people with Schizophrenia Disorder to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is comparing Neuronavigation-guided individualized iTBS with Control group: ordinary drug treatment for people with Schizophrenia or Transcranial Magnetic Stimulation. Participants receive Neuronavigation-guided individualized iTBS or Control group: ordinary drug treatment and complete study visits and assessments.
This study is looking at care and outcomes for people with Schizophrenia or Cognitive Impairment. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is comparing VV119 Placebo （in healthy adult subjects） with placebo for people with Schizophrenia. Participants receive VV119 Placebo （in healthy adult subjects） or placebo and complete study visits and assessments.
This study is looking at evaluate the dose levels, safety, and drug levels of KarXT intramuscular injection in participants with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.